CTLA4 and systemic lupus erythematosus: Additionally, CTLA4, a negative costimulatory molecule that curbs T cell activation and potentially limits T cell reactivity during inflammatory responses, exhibits genetic variability that has been correlated with an increased risk of developing SLE [90, 91].